The SBI Group develops and sells pharmaceuticals, health foods, and cosmetics that use the natural amino acid 5-ALA (5-aminolevulinic acid) in the Biotechnology, Healthcare ＆ Medical Informatics Business. As future focus areas, the Group is also developing a diverse range of businesses that go beyond its core competencies in financial fields for business development and to promote advanced initiatives. For instance, Web3 related business to evolve into a "digital space ecosystem" business such as the environment and energy that match Japan's national strategy, with collaboration with investees and partner companies that possess cutting-edge technologies and resources and developing businesses in Africa and other new overseas markets.